Novo Nordisk (NYSE: NVO) Stock Price Could Be Trading At A 48% Discount As Medicare Expands GLP-1 Coverage

Novo Nordisk (NYSE: NVO) has shed 32.7% of its value over the past three years, yet multiple valuation frameworks suggest the shares may be trading well below their intrinsic worth. Both a Discounted Cash Flow analysis and market multiple comparisons point to a meaningful gap between the current stock price and what the underlying business […] The post Novo Nordisk (NYSE: NVO) Stock Price Could Be Trading At A 48% Discount As Medicare Expands GLP-1 Coverage appeared first on Foreign Policy Journal .